Doctors have begun noticing a trend among their colleagues: many have visibly shed pounds, and it's all thanks to drugs like ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Finally, there are potential issues to be aware of that can lead to adverse outcomes, including: The manufacturer of Ozempic recently released a statement containing tips on protecting against ...
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
A gut microbe has been identified that mimics the effects of Ozempic to mitigate diabetes and obesity. Here's how to take advantage of it.
Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results